Clinical Trials Directory

Trials / Completed

CompletedNCT02003638

Assessment Of Vascular Health After Niacin Therapy (AVANT)

A 12-WEEK STUDY EVALUATING THE EFFECTS OF NIACIN ON VASCULAR HEALTH ASSESSED BY FLUORODEOXYGLUCOSE-PET/CT AND CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND MICROPARTICLES

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

This study is looking to see if niacin will lessen atherosclerotic plaque inflammation and favorably affect circulating levels of endothelial progenitor cells and microparticles in people with atherosclerotic disease on chronic statin therapy.

Conditions

Interventions

TypeNameDescription
DRUGNiacinNiacin titrated to 6000 mg daily
DRUGPlaceboPlacebo provided in the same pill quantity as niacin arm

Timeline

Start date
2012-03-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2013-12-06
Last updated
2014-06-25
Results posted
2014-06-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02003638. Inclusion in this directory is not an endorsement.

Assessment Of Vascular Health After Niacin Therapy (AVANT) (NCT02003638) · Clinical Trials Directory